Mental and behavioural disorders due to use of opioids. Opioid abuse with opioid-induced mood disorder
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Having informed consent to participate in the research Methadone treatment for at least two weeks before the intervention Age 18- 50 years old Minimum grade education
Exclusion criteria
Exclusion criteria: The absence of more than two sessions Suicidal thoughts or dangers that It is not possible to keep the dosage fixed Having severe psychiatric disorders such as schizophrenia Consuming multiple substance History of injury to the head History of epileptic seizures
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Brain- derived neurotrophic factor (BDNF). Timepoint: pretest-post test. Method of measurement: Eliza kit. | — |
Secondary
| Measure | Time frame |
|---|---|
| Interleukin 6 (IL-6). Timepoint: pretest-post test. Method of measurement: Eliza kit.;Tumor necrosis factor-( TNF-a). Timepoint: pretest-post test. Method of measurement: Eliza kit.;Quantitative EEG (QEEG). Timepoint: pretest-post test. Method of measurement: Mitsar set.;BART Impassivity. Timepoint: pretest- post test. Method of measurement: BART Impassivity questionnaire.;Craving. Timepoint: pretest- post test. Method of measurement: Desires for Drugs Questionnaire (DDQ).;Sub scale anxiety -DASS. Timepoint: pretest- post test. Method of measurement: depression sub scale(DASS).;Decision making ablity. Timepoint: pretest-post test. Method of measurement: IUWA Gambling Task. | — |
Countries
Iran (Islamic Republic of)
Contacts
Zanjan University of Medical Sciences